Skip to content

Non-surgical treatment of peri-implantitis, a randomized, single blind, controlled trial

Non-surgical treatment of peri-implantitis, a randomized, single blind, controlled trial - Non-surgical treatment of peri-implantitis

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON41564
Enrollment
48
Registered
2012-10-30
Start date
2012-11-21
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammation of the supporting tissues around a dental implant

Interventions

Non-surgical treatment (mechanical cleaning of the implant surface) of peri-implantitis with adjunctive use of systemic antibiotics (amoxicillin 375mg and metronidazole 250mg three times a day for 7

Sponsors

Vrije Universiteit
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Dentate or edentate patients with at least one screw-type titanium implant;The implant should be in function for at least a period of 12 months;Peri-implant intraosseous defect with at least 3 mm depth measured from the neck. The extent of bone loss will be measured on the basis of peri-apical radiographs;Probing depth at the deepest site at least 5mm combined with bleeding and/or suppuration;Patient above 18 years of age;Psychological appropriateness;Signed Informed Consent obtained prior to start

Exclusion criteria

Exclusion criteria: Patient with a history of taking systemic antibiotics in the preceding 3 months;Patient allergic to penicillin (amoxicillin) or metronidazole ;Systemic diseases like diabetes, HIV, Sjögren, SLE;Use of NSAID*s in the last 4 weeks;Current pregnancy or lactating;Mobile implants

Design outcomes

Primary

MeasureTime frame
The main outcome is the clinical attachment level (CAL).

Secondary

MeasureTime frame
Clinical parameters (pocket probing depth (PPD), bleeding on probing (BoP), plaque-accumulation and bone loss) and microbiological parameters.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)